Yo-Ting Tsai

9PUBLICATIONS
68CO-AUTHORS
Tumour immunologyMolecular targetsTissue engineeringApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 22, 2026
Blockade of Tumor-Intrinsic TGFβ Signaling Drives Hyperprogression in Small Cell Lung Cancer.

|Jun 23, 2025
Programmed death-1 inhibition increases vaccine-induced T-cell infiltration in patients with prostate cancer.

Wiem Lassoued, Ravi A Madan, Elisabetta Xue

|Mar 17, 2024
Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade.

Yo-Ting Tsai, Jeffrey Schlom, Renee N Donahue

|Mar 14, 2024
Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer.

Arun Rajan, Houssein Abdul Sater, Osama Rahma

|Nov 29, 2023
A T cell receptor β chain-directed antibody fusion molecule activates and expands subsets of T cells to promote antitumor activity.

Jonathan Hsu, Renee N Donahue, Madan Katragadda

|May 26, 2023
First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma.

Julius Strauss, Jean-Laurent Deville, Mario Sznol

Pageof 2

Frequent Collaborators

9 joint publications

Jeffrey Schlom

8 joint publications

James L Gulley

7 joint publications

Renee N Donahue

2 joint publications

Caroline Jochems